Treace Medical Concepts reported a quarterly loss of $0.28 per share, outperforming the Zacks Consensus Estimate of a $0.31 loss by $0.03 per share. The result was still worse than the $0.25 per share loss recorded a year ago, indicating modest year-over-year deterioration despite the beat versus expectations.
Treace Medical Concepts reported a quarterly loss of $0.28 per share, outperforming the Zacks Consensus Estimate of a $0.31 loss by $0.03 per share. The result was still worse than the $0.25 per share loss recorded a year ago, indicating modest year-over-year deterioration despite the beat versus expectations.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request a DemoOverall Sentiment
neutral
Sentiment Score
0.15
Ticker Sentiment
